Skip to main content

Table 2 Prevalence of Blastocystis and subtypes, gut intestinal in FACSA and UNEME cohort

From: Prevalence of Blastocystis and its association with Firmicutes/Bacteroidetes ratio in clinically healthy and metabolically ill subjects

 

Total

FACSA

UNEME

Blastocystis, n (%).

153 (52.46)

94 (47.0)

55 (65.48)*

 Subtype 1 (ST1)

22 (14.86)

14 (14.89)

8 (14.81)

 Subtype 2 (ST2)

14 (8.78)

8 (8.51)

5 (9.26)

 Subtype 3 (ST3)

42 (28.38)

28 (29.79)

14 (25.93)

 Subtype 4(ST4)

21 (14.19)

16 (17.02)

5 (9.26)

 Subtype 5 (ST5)

21 (14.19)

5 (5.32)

16 (29.63)*

 Subtype 7 (ST7)

21 (14.19)

12 (12.77)

9 (16.67)

Gut microbiota

 RAUF, Median IR

1.07 (0.23–2.35)

0.80 (0.05–2.08)

1.92 (0.71–3.53)*

 RAUB, Median IR

0.96 (0.47–2.11)

0.82 (0.44–1.65)

1.16 (0.63–3.29)*

 F/B ratio, Median IR

0.95 (0.22–3.50)

0.83 (0.07–3.50)

1.40 (0.32–4.03)*

  1. n Number, (%) Percentage, IR Interquartile range, RAUF Relative abundance units Firmicutes, RAUB Relative abundance units Bacteroidetes, F/B ratio Firmicutes/Bacteroidetes ratio. x2, Mann-Whitney-Wilcoxon
  2. * p < 0.05
Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us